Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone for HIV-Associated Weight Loss
NCT00260143Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in HIV wasting syndrome comparing Testosterone enanthate with Placebo (2 arms). Primary endpoints: Change in stair climbing power at 16 weeks, Change in walking speed at 16 weeks and 1 more. Started May 2003; status: completed.
02
Drugs
testosterone enanthate
03
Conditions
HIV wasting syndrome
Beyond the preview
Go deeper on NCT00260143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260143.